Table 2 Results of univariate Cox proportional-hazards regression analyzing the effect of baseline variables on in-hospital death
From: Prognostic value of NT-proBNP in patients with severe COVID-19
Characteristics | HR (95%CI) | P | |
|---|---|---|---|
Sex | Male | – | |
Female | 0.348 (0.130–0.930) | 0.035 | |
Age, per 10 years | 1.975 (1.309–2.981) | 0.001 | |
History of HP | no | – | – |
yes | 4.044 (1.604–10.200) | 0.003 | |
History of CHD | no | – | – |
yes | 2.652 (0.992–7.092) | 0.052 | |
History of COPD | no | – | – |
yes | 4.127 (0.945–18.024) | 0.059 | |
History of DM | no | – | – |
yes | 0.958 (0.277–3.314) | 0.947 | |
NT-proBNP, per 100 pg/ml | 1.369 (1.217–1.541) | < 0.001 | |
MYO, per 1 ng/ml | 1.006 (1.003–1.008) | < 0.001 | |
CK-MB, per 1 μg/L | 1.259 (1.098–1.443) | 0.001 | |
Hs-TnI, per 1 ng/ml | 1.862 (1.273–2.722) | 0.001 | |
Urea, per 1 mmol/L | 1.134 (1.073–1.198) | < 0.001 | |
Creatinine, per 1 umol/L | 1.028 (1.013–1.043) | < 0.001 | |
WBC, per 1 × 109/L | 1.150 (1.076–1.229) | < 0.001 | |
LYM, per 1 × 109/L | 0.065 (0.017–0.249) | < 0.001 | |
CRP, per 1 mg/L | 1.021 (1.012–1.030) | < 0.001 | |
PCT, per 0.1 ng/ml | 1.241 (1.142–1.349) | < 0.001 | |